Cilfa Opposition, Las191954, (Ar100620 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, AMLODIPINE, LOSARTÁN AND ROSUVASTATINA, (AR098417A1)
Countries: Argentina Date: 2017
-
CILFA opposition, mesalazine, (AR108231A1)
Countries: Argentina Date: 2018
-
CILFA opposition, estradiol, (AR107022A1)
Countries: Argentina Date: 2019
-
CILFA opposition, fenibrutinib, (AR107751A1)
Countries: Argentina Date: 2018
-
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098982A1)
Countries: Argentina Date: 2016
-
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098983A1)
Countries: Argentina Date: 2016
-
CILFA opposition, Navafenterol sacchrinate in combination with corticosteroids, (AR094910A1)
Countries: Argentina Date: 2016
-
CILFA opposition, 1 1 -beta-hydroxysteroid dehydrogenase 1 , (AR090999A1)
Countries: Argentina Date: 2015
-
CILFA opposition, tobramycin, (AR092318A1)
Countries: Argentina Date: 2015
-
CILFA opposition, bromhexine, (AR082381A1)
Countries: Argentina Date: 2013